Trena-Med-A, Trenbolone Acetate, 100 mg/ml, 10 ml

Trenbolone Acetate 100 mg/ml by Bioniche Pharma is a high-potency, short-ester parenteral formulation designed for rapid anabolic activity. Engineered by Bioniche Pharma to ensure high binding affinity to intracellular androgen receptors, Bioniche Pharma Trenbolone Acetate delivers swift therapeutic action without aromatizing into estrogen, driving significant lean tissue preservation, cellular recovery, and optimal nitrogen retention.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

Bioniche Pharma Trenbolone Acetate exerts strong anabolic and androgenic effects by engaging intracellular androgen receptors with high affinity. It stimulates muscle protein synthesis, accelerates cellular nitrogen conservation, and elevates localized IGF-1 expression within skeletal muscle tissue. Lacking a 4,5-double bond aromatization site, Trenbolone Acetate by Bioniche Pharma does not convert to estradiol. The short acetate ester ensures a rapid pharmacokinetic release, requiring regular administration to maintain stable circulating hormone levels.

INDICATIONS & CLINICAL USE

• Targeted anabolic management to promote protein synthesis, cellular repair, and lean tissue preservation using Bioniche Pharma Trenbolone Acetate.
• Adjunctive therapy for catabolic muscle wasting disorders and involuntary weight loss under qualified clinical oversight.

CONTRAINDICATIONS

• Male patients with diagnosed or suspected prostate carcinoma or male breast cancer.
• Female patients who are pregnant, nursing, or planning pregnancy, owing to severe risks of fetal virilization, structural defects, and endocrine toxicity.
• Pediatric patients, children, and adolescents.
• Known hypersensitivity or allergic response to Trenbolone Acetate, carrier oils, or inactive compounding excipients in Bioniche Pharma preparations.

WARNINGS & SPECIAL PRECAUTIONS

• Cardiovascular Supervision: Middle-aged and elderly male patients with existing angina pectoris, coronary artery disease, or circulatory impairment should receive Bioniche Pharma Trenbolone Acetate only under strict medical supervision.
• Nephrotoxicity & Renal Monitoring: Extended use or elevated dosages of Trenbolone Acetate by Bioniche Pharma may place strain on renal function. Darkened urine can indicate heightened renal strain; adequate hydration and periodic renal function testing are strongly advised.

ADVERSE REACTIONS

• Cardiovascular & Systemic: Elevated blood pressure (hypertension), nasal bleeding (epistaxis), hot flashes, headaches, and transient nausea during Bioniche Pharma Trenbolone Acetate treatment.
• Dermatological & Behavioral: Increased sebum production, severe acne vulgaris, and noticeable changes in mood, irritability, or aggressiveness.
• Endocrine & Reproductive: Deep suppression of the Hypothalamic-Pituitary-Testicular Axis (HPTA), leading to testicular atrophy, reduced sperm count, and secondary hypogonadism.

DOSAGE & ADMINISTRATION

Trenbolone Acetate by Bioniche Pharma is formulated exclusively for deep intramuscular injection. Given the fast-acting nature of the acetate ester, dosing intervals should be carefully maintained:

• Adult Dosage: Standard administration ranges from 100 mg given 1 to 3 times weekly (totaling 100 mg to 300 mg weekly), adjusted according to medical guidance and response.
• Restricted Populations: Strictly contraindicated for use in female patients, children, and adolescents.

STORAGE & HANDLING

Store Bioniche Pharma Trenbolone Acetate in a cool, dry place shielded from direct light exposure and excessive heat. Do not refrigerate or freeze. Keep strictly out of the reach and sight of children.